Assessment of immunogenicity from galcanezumab phase 3 trials in patients with episodic or chronic migraine
Martinez, James M, Hindiyeh, Nada, Anglin, Greg, Kalidas, Kavita, Hodsdon, Michael E, Kielbasa, William, Moser, Brian A, Pearlman, Eric M, Garces, SandraJournal:
Cephalalgia
DOI:
10.1177/0333102420920642
Date:
April, 2020
File:
PDF, 652 KB
2020